Publications by authors named "Mark Schactman"

Claim this Profile
P
Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists.
Li-Tzy Wu, Jacquie King, Kathryn Hefner, Mark Schactman, William John

Addict Sci Clin Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.
Gail D'Onofrio, Andrew A Herring, Jeanmarie Perrone, Kathryn Hawk, Elizabeth A Samuels, Mark Schactman

JAMA Netw Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool.
Benjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, Albert A Taylor, Mark Schactman

Amyotroph Lateral Scler Frontotemporal Degener· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic.
Danielle Beaulieu, James D Berry, Sabrina Paganoni, Jonathan D Glass, Christina Fournier, Mark Schactman

Amyotroph Lateral Scler Frontotemporal Degener· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
Milton Packer, Christopher O'Connor, John J V McMurray, Janet Wittes, William T Abraham, Mark Schactman

N Engl J Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On independent data monitoring committees in oncology clinical trials.
Janet Wittes, Mark Schactman

Chin Clin Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.
Alejandra T Perez, Banu Arun, Debu Tripathy, Mary A Tagliaferri, Heather S Shaw, Mark Schactman

Breast Cancer Res Treat· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis